Hop inhibitors belong to a specific category of chemical compounds that are characterized by their ability to interfere with the function of the heat shock proteins (Hsps). The Hop protein, also known as Hsp70-Hsp90 Organizing Protein, plays a crucial role in mediating the transfer of client proteins between Hsp70 and Hsp90, which are essential components of the cellular protein quality control system. By disrupting this process, hop inhibitors impair the proper folding, stabilization, and activity of a wide range of client proteins, ultimately affecting cellular homeostasis and function. These compounds exhibit a diverse range of chemical structures, reflecting the complexity and specificity of their target interactions.
The mechanism of action of hop inhibitors primarily involves binding to the tetratricopeptide repeat (TPR) domain of Hop, which is responsible for its interaction with Hsp70 and Hsp90. This binding prevents the formation of the Hsp70-Hop-Hsp90 complex, leading to a disruption in the chaperone cycle and affecting protein maturation. Given the central role of Hsps in maintaining protein stability and function, hop inhibitors have the potential to impact a wide variety of cellular processes. Research on these compounds has provided valuable insights into the intricate network of protein-protein interactions and the mechanisms that govern cellular proteostasis. Through their unique ability to modulate the function of heat shock proteins, hop inhibitors serve as crucial tools for unraveling the complexities of cellular function and the delicate balance that maintains proteome stability.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor that could change chromatin accessibility, potentially affecting HOPX expression. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
A tyrosine kinase inhibitor that could affect signaling pathways regulating HOPX. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
An EGFR inhibitor that might influence HOPX expression through EGFR signaling pathways. | ||||||
Chromomycin A3 | 7059-24-7 | sc-200907 | 10 mg | $260.00 | ||
Binds to DNA and could potentially affect chromatin structure and HOPX expression. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that might indirectly influence HOPX protein levels by affecting its degradation. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Inhibits RNA polymerase, potentially reducing HOPX mRNA synthesis. | ||||||